The use of tiletamine hydrochloride and zolazepam hydrochloride for sedation of the mountain brushtial possum, Trichosurus caninus Ogilby (Phalangeridae: Marsupialia).
A combination of tiletamine hydrochloride and zolazepam hydrochloride in a 1:1 ration by weight was used successfully to sedate mountain brushtail possums, Trichosurus caninus, in the field. A standard total dose of 50 to 60 mg provided adequate sedation for the completion of a range of handling procedures. We describe the induction time, dose rate and side-effects associated with the use of tiletamine and zolazepam in T caninus.
Division of Biochemistry and Molecular Biology, Australian National University, Canberra.
K L
KL
Viggers
D B
DB
Lindenmayer
D000758:Anesthesia / Q000662:veterinary*; D000778:Anesthetics, Dissociative / Q000008:administration & dosage / Q000009:adverse effects; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects; D007103:Immobilization; D007273:Injections, Intramuscular / Q000662:veterinary; D008297:Male; D009126:Muscle Relaxation / Q000187:drug effects; D009893:Opossums / Q000502:physiology*; D012119:Respiration / Q000187:drug effects; D013992:Tiletamine / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors; D015041:Zolazepam / Q000008:administration & dosage / Q000009:adverse effects
D000778:Anesthetics, Dissociative; D006993:Hypnotics and Sedatives; D013992:Tiletamine; D015041:Zolazepam